Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Gregory Kricorian"'
Autor:
Dimitrios A. Pappas, Jacqueline O’Brien, Lin Guo, Ying Shan, Joshua F. Baker, Gregory Kricorian, Scott Stryker, David H. Collier
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-10 (2023)
Abstract Background Real-world studies assessing the comparative effectiveness of biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) as first-line targeted therapy are scarce. We analyzed the real-world persistence and
Externí odkaz:
https://doaj.org/article/d0064a88add9404883895a3a6f26b1f8
Autor:
Philip J. Mease, Jacqueline O'Brien, Nicole Middaugh, Gregory Kricorian, Scott Stryker, David H. Collier, Alexis Ogdie
Publikováno v:
ACR Open Rheumatology, Vol 5, Iss 8, Pp 388-398 (2023)
Objective Real‐world studies assessing treatment response by psoriatic arthritis (PsA) domains are limited. This study aimed to describe the patient characteristics, frequency and combinations of disease domains, disease activity, and patient‐rep
Externí odkaz:
https://doaj.org/article/e7cde6931ae94e99a1ad7f49603618fd
Autor:
Atul Deodhar, Arthur Kavanaugh, Dafna D Gladman, Laura C Coates, Vibeke Strand, Philip S Helliwell, Alexis Ogdie, Lyrica X H Liu, Gregory Kricorian, David Collier, Phillip J Mease
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objective We used the Study of Etanercept And Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA) data set to examine the impact of presence of enthesitis, dactylitis, nail disease and/or psoriasis on treatme
Externí odkaz:
https://doaj.org/article/d27b191a16d84799a9c5014934b2f0a7
Autor:
Vibeke Strand, Ervant J Maksabedian Hernandez, Bradley S Stolshek, Lyrica X H Liu, David H Collier, Gregory Kricorian
Publikováno v:
RMD Open, Vol 7, Iss 1 (2021)
Objectives We examined patient-reported outcomes (PROs) in The Study of Etanercept And Methotrexate in Patients with Psoriatic Arthritis (PsA); a 48-week, phase 3, randomised controlled trial that compared outcomes with methotrexate (MTX) monotherapy
Externí odkaz:
https://doaj.org/article/cddd1c3819a245839e9b239f459eb3f3
Autor:
Laura Stradford, Elaine Karis, Hong Zhao, Gregory Kricorian, Scott Stryker, Jeffrey R. Curtis, K. Gavigan, Fenglong Xie, Shilpa Venkatachalam, Lang Chen, Huifeng Yun, W. Benjamin Nowell
Publikováno v:
Rheumatology and Therapy
Introduction The magnitude and frequency of temporally related methotrexate (MTX)-associated side effects in rheumatoid arthritis (RA) or psoriatic arthritis (PsA) patients are difficult to quantify using traditional research methods. As proof of con
Autor:
Philip S Helliwell, Phillip J Mease, Arthur Kavanaugh, Laura C Coates, Alexis Ogdie, Atul Deodhar, Vibeke Strand, Gregory Kricorian, Lyrica X H Liu, David Collier, Dafna D Gladman
Publikováno v:
RMD Open. 8:e002366
ObjectiveWe used the Study of Etanercept And Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA) data set to examine the impact of presence of enthesitis, dactylitis, nail disease and/or psoriasis on treatmen
Autor:
Christopher T. Ritchlin, Philip J. Mease, David H. Collier, Philip S. Helliwell, Lyrica Liu, Dafna D. Gladman, Gregory Kricorian, James B. Chung
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
Objective To examine the efficacy of methotrexate monotherapy relative to etanercept monotherapy and the value of combining methotrexate and etanercept for the treatment of patients with psoriatic arthritis (PsA). Methods In this double-blind study,
Publikováno v:
Pediatric Dermatology
Background/Objective Compared with the adult psoriasis population, knowledge about the incidence of comorbidities in the pediatric psoriasis population is limited. The objective of this study was to assess the prevalence and incidence of comorbiditie
Autor:
David H. Collier, Philip S. Helliwell, Lyrica Liu, Leonieke J J van Mens, Alexis Ogdie, Vibeke Strand, Philip J. Mease, Laura C. Coates, Priscilla K Yen, Dafna D. Gladman, James B. Chung, Joseph F. Merola, Gregory Kricorian
Publikováno v:
Rheumatology (Oxford, England)
Objectives To examine which composite measures are most sensitive to change when measuring psoriatic arthritis (PsA) disease activity, analyses compared the responsiveness of composite measures used in a 48-week randomized, controlled trial of MTX an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e437b7323969be83fae7b7caa6eed938
https://doi.org/10.1093/rheumatology/keaa271
https://doi.org/10.1093/rheumatology/keaa271
Publikováno v:
Journal of drugs in dermatology : JDD. 19(4)
Background: Patients with moderate-to-severe psoriasis can have symptoms resulting in significant impact on patient-reported outcomes (PROs). The effect of etanercept (ETN) in moderate-to-severe psoriasis patients who previously received apremilast (